RecruitingNCT04709432

ECMO Treatment of Children in China in the Past 10 Years

Extracorporeal Membrane Oxygenation (ECMO) Treatment of Children in Mainland China in the Past 10 Years


Sponsor

Children's Hospital of Fudan University

Enrollment

500 participants

Start Date

Jan 11, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

It is a cross-sectional study to summarize the extracorporeal membrane oxygenation (ECMO)treatment in children in China.


Eligibility

Min Age: 1 DayMax Age: 18 Years

Inclusion Criteria2

  • age of 1d to 18 years old;
  • children supported by ECMO in mainland China in the past 10 years

Exclusion Criteria1

  • none

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREECMO

ECMO is a form of Extracorporeal Life Support (ECLS) to support either the pulmonary, or both the pulmonary and cardiac systems.


Locations(1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04709432


Related Trials